Measles, mumps and rubella outbreaks still represent an healthcare issue, even though major advancements have been done towards their eradication. A poor inclination towards Mmr (measles-mumps-rubella) vaccination may constitute a major cause of increased risk to contract one of these diseases amongst specific population groups like migrants, alternative medicine users, some religious groups, healthcare professionals.
Information on Mmr vaccines coverage amongst these and others “hard-to-reach” groups was included in a document made and published Ecdc in range of the European project Venice II (Vaccine European New Integrated Collaboration Effort II). Main aim of the document was to provide a complete review of measles, mumps and rubella focuses which have been reported in the last twenty years in Europe.
An update on Mmr
Primary tabs
Autori:
Sezioni:
Indice:
Vaccination
prossimo articolo
Germany: world champions also for funding research
Surpassed only by the United States, China and Japan for R&D allocated funds, Germany has decided to raise the biddings and has pledged around 31.6 million dollar in the next 6 years to support specials research and higher education programmes. Germany, which celebrates the twentieth anniversary of the fall of the Berlin wall, is the most populous nation in Europe and the most important economy of the Old Continent, with 100 billion dollars spent every year in research and development. The funds for special programmes have remained